BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rouers EDM, Bruijning-Verhagen PCJ, van Gageldonk PGM, van Dongen JAP, Sanders EAM, Berbers GAM. Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants. JAMA 2020;324:1068-77. [PMID: 32930758 DOI: 10.1001/jama.2020.12316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Fortmann MI, Dirks J, Goedicke-Fritz S, Liese J, Zemlin M, Morbach H, Härtel C. Immunization of preterm infants: current evidence and future strategies to individualized approaches. Semin Immunopathol 2022. [PMID: 35922638 DOI: 10.1007/s00281-022-00957-1] [Reference Citation Analysis]
2 Faingelernt Y, Dagan R, Givon-Lavi N, van der Beek BA, Ben-Shimol S, Shany E, Greenberg D. The impact of the pneumococcal conjugate vaccines on the incidence of community-acquired alveolar pneumonia in premature compared with in term-born infants. Vaccine 2022;40:568-73. [PMID: 34973848 DOI: 10.1016/j.vaccine.2021.12.025] [Reference Citation Analysis]
3 Sheridan S, Mcintyre P, Liu B, Fathima P, Snelling T, Blyth C, Klerk ND, Moore H, Gidding H. Pertussis burden and acellular pertussis vaccine effectiveness in high risk children. Vaccine 2022. [DOI: 10.1016/j.vaccine.2021.10.013] [Reference Citation Analysis]
4 van Dongen JAP, Rouers EDM, Schuurman R, Band C, Watkins SM, van Houten MA, Bont LJ, Norbruis OF, Hemels MAC, van Well GTJ, Vlieger AM, van der Sluijs J, Stas HG, Tramper-Stranders G, Kleinlugtenbeld EA, van Kempen AAMW, Wessels M, van Rossem MC, Dassel CACM, Pajkrt D, Bonten MJM, Bruijning-Verhagen PCJ. Rotavirus Vaccine Safety and Effectiveness in Infants With High-Risk Medical Conditions. Pediatrics 2021;148:e2021051901. [PMID: 34814164 DOI: 10.1542/peds.2021-051901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? Drugs 2020;80:1383-96. [PMID: 32705604 DOI: 10.1007/s40265-020-01365-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
6 Härter G, Spinner CD, Roider J, Bickel M, Krznaric I, Grunwald S, Schabaz F, Gillor D, Postel N, Mueller MC, Müller M, Römer K, Schewe K, Hoffmann C. COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients. Infection 2020;48:681-6. [PMID: 32394344 DOI: 10.1007/s15010-020-01438-z] [Cited by in Crossref: 78] [Cited by in F6Publishing: 92] [Article Influence: 39.0] [Reference Citation Analysis]